Amyloid fibril formation by human stefin B: influence of pH and TFE on fibril growth and morphology

被引:48
|
作者
Zerovnik, Eva
Skarabot, Miha
Skerget, Katja
Giannini, Silva
Stoka, Veronika
Jenko-Kokalj, Sasa
Staniforth, Rosemary A.
机构
[1] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana 1000, Slovenia
[2] Jozef Stefan Inst, Dept Condensed Matter Phys, Ljubljana 1000, Slovenia
[3] Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England
来源
基金
英国生物技术与生命科学研究理事会;
关键词
amyloid fibrils; cystatins; flow cytometry; lag phase oligomers; morphology by AFM; TFE effect on the kinetics;
D O I
10.1080/13506120701461137
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As shown before, human stefin B (cystatin B) populates two partly unfolded species, a native-like state at pH 4.8 and a structured molten globule state at pH 3.3 (high ionic strength), from each of which amyloid fibrils grow. Here, we show that the fibrils obtained at pH 3.3 differ from those at pH 4.8 and that those obtained at pH 3.3 (protofibrils) do not transform readily to mature fibrils. In addition we show that amorphous aggregates are also a source of fibrils. The kinetics of amyloid fibril formation at different trifluoroethanol (TFE) concentrations were measured. TFE accelerates fibril growth at preclenaturational concentrations of the alcohol. At concentrations higher than 10%, the fibrillar yield decreases proportionately as the population of an all alpha-helical, denatured form of the protein increases. At an optimum TFE concentration, the lag and the growth phases are observed, similarly to some other amyloidogenic proteins. Morphology of the protein species at the beginning and the end of the reactions was observed using atomic force microscopy and transmission electron microscopy. Final fibril morphologies differ depending on solvent conditions.
引用
收藏
页码:237 / 247
页数:11
相关论文
共 50 条
  • [21] Thermodynamics of β-amyloid fibril formation
    Tiana, G
    Simona, F
    Brogliaa, RA
    Colombo, G
    JOURNAL OF CHEMICAL PHYSICS, 2004, 120 (17): : 8307 - 8317
  • [22] Modeling amyloid fibril formation
    N. V. Dovidchenko
    O. V. Galzitskaya
    Biochemistry (Moscow), 2011, 76 : 366 - 373
  • [23] Mechanisms of Amyloid Fibril Formation
    Dovidchenko, N. V.
    Leonova, E. I.
    Galzitskaya, O. V.
    BIOCHEMISTRY-MOSCOW, 2014, 79 (13) : 1515 - 1527
  • [24] Amyloid fibril formation of the mouse VL domain at acidic pH
    Martsev, SP
    Dubnovitsky, AP
    Vlasov, AP
    Hoshino, M
    Hasegawa, K
    Naiki, H
    Goto, Y
    BIOCHEMISTRY, 2002, 41 (10) : 3389 - 3395
  • [25] Modeling of amyloid fibril formation
    Dovidchenko, N. V.
    Galzitskaya, O. V.
    FEBS JOURNAL, 2011, 278 : 368 - 368
  • [26] Copper and amyloid fibril formation
    Brown, David R.
    FEBS JOURNAL, 2007, 274 (15) : 3755 - 3755
  • [27] Amyloid Fibril Formation by β-Casein and Its Influence Factor
    Liu Jihua
    Carver, John A.
    Thorn, David C.
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2014, 35 (05): : 976 - 980
  • [28] Sucrose modulates insulin amyloid-like fibril formation: effect on the aggregation mechanism and fibril morphology
    Marasini, Carlotta
    Vesterga, Bente
    Vestergaard, Bente
    RSC ADVANCES, 2017, 7 (17): : 10487 - 10493
  • [29] Sucrose modulates insulin amyloid-like fibril formation: effect on the aggregation mechanism and fibril morphology
    Marasini C.
    Foderà V.
    Vestergaard B.
    Marasini, C. (carlotta.marasini@sund.ku.dk), 1600, Royal Society of Chemistry (07): : 10487 - 10493
  • [30] In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1
    Rabzelj, S
    Turk, V
    Zerovnik, E
    PROTEIN SCIENCE, 2005, 14 (10) : 2713 - 2722